Ignyta (RXDX) Appoints Adrian Senderowicz, M.D., As Chief Medical Officer And Senior Vice President, Clinical Development And Regulatory Affairs
8/11/2014 8:23:36 AM
SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that Adrian Senderowicz, M.D., has been appointed as Chief Medical Officer and Senior Vice President, Clinical Development and Regulatory Affairs.
“Adrian’s deep experience in clinical, research, development and regulatory affairs in the oncology setting will be extremely valuable to Ignyta,” said Jonathan Lim, M.D., Chairman and CEO of Ignyta. “His extensive experience in large pharma and biotech, as well as with the FDA and NCI, will make him instrumental to the company's success as we strive to provide new treatment options for patients with our proprietary oncology drug development programs.”
Help employers find you! Check out all the jobs and post your resume.
comments powered by